Cargando…
Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery
BACKGROUND: Unfractionated heparin (UFH) is widely used as a reversible anti-coagulant in cardiopulmonary bypass (CPB). However, the pharmacokinetic characteristics of UFH in CPB surgeries remain unknown because of the lack of means to directly determine plasma UFH concentrations. The aim of this st...
Autores principales: | Jia, Zaishen, Tian, Ganzhong, Ren, Yupeng, Sun, Zhiquan, Lu, Wei, Hou, Xiaotong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326208/ https://www.ncbi.nlm.nih.gov/pubmed/25638272 http://dx.doi.org/10.1186/s12967-015-0404-5 |
Ejemplares similares
-
Individual variation in unfractionated heparin dosing after pediatric cardiac surgery
por: Hikino, Keiko, et al.
Publicado: (2020) -
Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery
por: Chen, Yufan, et al.
Publicado: (2022) -
Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014) -
Use of a fixed, body weight-unadjusted loading dose of unfractionated heparin for extracorporeal cardiopulmonary resuscitation
por: Iwashita, Yoshiaki, et al.
Publicado: (2015) -
Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)